Thanks to the DP-rupture software, the Order of Pharmacists recorded 539 drugs in difficulty of supply. The ANSM only identifies 45 missing specialties.
“We are going to discover thanks to a new pilot software set up that it is not at all 45 drugs that have supply difficulties, but that it is much more! », Announced Isabelle Adenot, President of the Order of Pharmacists in why actor in the month of September. And the pharmacist has obviously got it right. The latter confirms, in fact, this morning in the columns of Figaro that “in the month of September, we counted 539 missing drugs. “. Results on the difficulties of supplying drugs in pharmacies far removed from the figures online on the website of theMedicines Safety Agency (ANSM).
The DP-rupture allows for better photography
In fact, the Agency’s website currently reports 45 specialties that are out of stock. According to the Ansm, nervous system drugs (18%), anti-infectives (17%) and anticancer drugs (11%) are the most affected classes. Regarding Levothyrox, a drug prescribed to 3 million French people to regulate their thyroid, it is still threatened with out of stock.
So, to collect results that are closer to reality, an alert system was created allowing pharmacists to send instantaneous information to the laboratory and to Ansm in the event of a break in their orders. This is the DP-rupture, a computer software developed in partnership with all the health authorities and the Ministry of Health.
The missing drugs will be more and more numerous
“Drug stockouts are a problem that will unfortunately continue to grow. This global phenomenon is very difficult to resolve, ”also noted Isabelle Adenot. The president of the Order of Pharmacists linked these problems to manufacturing defects. “When there were earthquakes in Italy, some factories were the only ones to manufacture certain drugs. When the plant can no longer function, necessarily, behind, there is something missing, ”she said.
Another explanation put forward by Isabelle Adenot, that of the wholesale distributors who, for some, buy en masse stocks of drugs in countries manufacturing them at low prices. The goal of the maneuver? Then resell these specialties in countries where they are marketed more expensive. This rush for these low-cost stocks sometimes causes a disruption in the supply chain and in some cases even creates stockouts.
.
